Sunil Agarwal

Sunil Agarwal has an estimated net worth of $10.2 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Ultragenyx Pharmaceutical Inc., MyoKardia, Inc., Calithera Biosciences, Inc., Juno Therapeutics, Inc., ARVINAS, INC., and Astria Therapeutics, Inc..

2020 was Sunil Agarwal's most active year for acquiring shares with 6 total transactions. Sunil Agarwal's most active month to acquire stocks was the month of May. 2015 was Sunil Agarwal's most active year for disposing of shares, totalling 17 transactions. Sunil Agarwal's most active month to dispose stocks was the month of July. 2015 saw Sunil Agarwal paying a total of $558,800.00 for 62,700 shares, this is the most they've acquired in one year. In 2021 Sunil Agarwal cashed out on 60,000 shares for a total of $1,564,056.92, their largest year based on trade value.